Dr. Irene J. Tan, MD

Dr. Tan practices at Jefferson Einstein Philadelphia Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University.

Dr. Tan's NPI, 1083684500, was assigned on January 26, 2006. Dr. Tan graduated from State University of New York Downstate Medical Center in 1994. Dr. Tan holds Pennsylvania license MD445427.

Dr. Tan's primary practice is Jefferson Einstein Philadelphia Hospital, at 5501 Old York Road, Philadelphia, PA 19141 in Philadelphia County. The practice phone is (215) 456-6090.

Dr. Tan's primary practice is Jefferson Einstein Philadelphia Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University. The medical group on file is Temple Faculty Physicians. Dmand AI also links Dr. Tan to 1 more dialysis center, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tan practices, 3 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Tan's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Tan is licensed in Pennsylvania.

CMS data shows 254 Medicare services from Dr. Tan across 3 procedure codes in 2024, for 97 Medicare patients. Medicare paid $16,265 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 97 Medicare patients who saw Dr. Tan in 2024. The largest group is 65 to 74, with 53 patients. 75% of them have arthritis, and 75% have high blood pressure. 49% are also on Medicaid. Their average risk score is 2.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tan's median patient age at 59, with 74% women.

In 2024, Dr. Tan wrote 846 Medicare Part D claims for 138 patients. 64% of them were for generic drugs. CMS names the drug for 805 of them, across 13 drugs with 11 or more claims each, at $2,014,718 in total drug cost. In 2023, CMS named 862 claims across 12 drugs.

Dr. Tan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tan as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 17 papers to Dr. Tan, published from 2014 to 2025. 2022 was the busiest year, with 3. Dr. Tan has published most often in Cureus. Dr. Tan's most frequent co-authors are Marcy B. Bolster, MD, Rafal Saad Ali, MD and Chaim Putterman, MD.

CMS Open Payments shows 10 general payments to Dr. Tan from 3 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 52% of the total. Novartis Pharmaceuticals Corporation paid the most, $750.

Dr. Tan graduated from State University of New York Downstate Medical Center in 1994.